Page 3 - Ascites News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Background: Paracentesis is commonly undertaken in patients with cancer-related ascites. Aim: To systematically investigate the symptomatic benefits and harms experienced by patients with cancer undergoing paracentesis using real-world data in the palliative care setting. Design: Prospective, multisite, observational, consecutive cohort study. Benefits and harms of paracentesis were assessed between 01/07/2018 and 31/02/2021 as part of routine clinical assessments by treating clinicians at four timepoints: (T0) before paracentesis; (T1) once drainage ceased; (T2) 24 h after T1 and (T3) 28 days...

These new thresholds are based on high-quality prospective data drawn from four randomized controlled trials.

Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.

A reduction in hepatic PPG soon after implantation of a transjugular intrahepatic portosystemic shunt was associated with improved ascites control at 6 weeks in a study published in Hepatology.

Alcohol-associated liver disease kills more people in US states with fewer gastroenterologists per capita.